Voso, Maria Teresa <br/><br/>
Rituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms.  [electronic resource] 

 -  Haematologica  Sep 2002 
 - 918-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0390-6078 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Murine-Derived<br/>B-Lymphocytes--cytology<br/>CD3 Complex--metabolism<br/>CD56 Antigen--metabolism<br/>Cell Count<br/>Cell Division--drug effects<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Humans<br/>Leukemia, B-Cell--pathology<br/>Lipopolysaccharide Receptors--metabolism<br/>Rituximab